BOSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- PathAI , a global leader in AI-powered pathology, today announced that the U.S. Food and Drug Administration (FDA) has qualified AIM-MASH AI Assist through ...
The MarketWatch News Department was not involved in the creation of this content. BOSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology, today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results